• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Trends in Cell Therapeutics: Promise and Reality

$3,500.00 – $7,000.00

Clear
SKU: KLI934189 Category: Biotechnology Market Research Pages: 232
  • Description
  • Table of Contents
  • Latest reports

Description

Cell and tissue therapies are about to revolutionize the treatment of a number of diseases, including: organ, replacement, cartilage, skin, autoimmune diseases, diabetes, neurodegenerative diseases, cancer and cardiovascular tissue damage. Although cell therapy is not a new phenomenon, what is new is the scope and versatility of research using stem cell and tissue therapeutics, and products based on combinations of cell therapy, gene manipulation, and tissue engineering.

The report provides world market projections 2002-2007, discusses market trends and issues including how bioethics debates are affecting development and what the best marketing models for these new therapies will be. The report also makes considered predictions about the companies and technologies to watch as the cell therapy industry evolves.

Table of Contents

Chapter One: Executive Summary

  • Scope and Methodology
  • Size and Growth of the Market
  • Market Trends

Chapter Two: Introduction

  • Cell Therapy—Past, Present, and Future
  • A Word About Stem Cells
  • Disease Opportunities and Scientific Reticence
  • Point of View

Chapter Three: Cell Technology Commercialization: The Journey from Bench to Clinic

  • Problems with Embryonic Stem Cells: It’s More than Ethics
  • Adult Stem Cells to the Rescue?
  • Autologous, Allogeneic, and Xenogenic Products
  • Cell Therapy Equipment and Accessories
  • Cloning and Bioengineering Cells and Tissues
  • The Journey Continues

Chapter Four: Market Trends and Issues

Population Demographics and The Demand for Cell and Tissue Products

  • Patent Issues
  • Technology and Reimbursement Issues
  • New Technology Commercialization
  • Regulatory Affairs
    • The European Union
    • Germany
    • France
    • Spain
    • United Kingdom
    • Sweden
    • Japan
    • China
    • Singapore
    • Israel
    • Canada
    • Australia
    • United States

Chapter Five: Cell Therapy Applications: Commercial and Non-Commercial Research

  • Cancer Vaccines
  • Cardiovascular Diseases
  • Diabetes
  • Electronic Tissue
  • Gene / Drug Delivery
  • Immune System Modulation
  • Nervous System Injuries / Neurological Diseases
  • Organ Replacement / Tissue Engineering
  • Miscellaneous Applications

Chapter Six: Market Analysis

  • Introduction
  • Bioengineered Skin Products
  • Bone and Cartilage
  • Stem Cell Therapy, 2002-2007
  • Cell therapy, 2005-2015
  • Company Mergers and Closures
  • Cell Cloning

Chapter Seven: Conclusions and Strategic Implications

  • First Conclusion
  • Implication
  • Second Conclusion
  • Implication
  • Third Conclusion
  • Implication
  • Fourth Conclusion
  • Implication
  • Fifth Conclusion
  • Implication

Chapter Eight: Companies and Technologies To Watch

Chapter Nine: Company Profiles

  • Aastrom Biosciences, Inc.
  • Advanced Cell Technology (ACT)
  • AmCyte Inc.
  • Anthrogenesis (Acquired by Celgene Corp.)
  • Artecel Inc. (formerly Artecel Sciences, Inc.)
  • Athersys Inc.
  • Baxter Healthcare Corporation
  • Bioheart Inc.
  • BresaGen Ltd.
  • Celgene Corporation
  • Cell Transplants International, LLC (CTI)
  • Celmed BioSciences Inc.
  • Chromos Molecular Systems Inc.
  • Diatranz, Ltd.
  • ES Cell International Pte Ltd (ESI)
  • Gamida-Cell Ltd.
  • GenVec Inc. / Diacrin
  • Geron Corporation
  • Immuno-Designed Molecules S.A. (IDM)
  • Kourion Therapeutics
  • LifeCell Corporation
  • Merix Bioscience, Inc.
  • MicroIslet Inc.
  • Nucleotech LLC
  • Osiris Therapeutics Inc.
  • Proneuron Biotechnologies Inc.
  • Transition Therapeutics Inc.
  • ViaCell, Inc.
  • Xcyte Therapies, Inc

Appendix A: List of Cell Therapy Companies and Their Products

Appendix B: Lexicon of Cell Therapy Terms

List of Exhibits

Chapter Three: Cell Technology Commercialization: The Journey from Bench to Clinic

  • Table 3-1: Providers of Currently Approved Cell Lines
  • Table 3-2: Selected Companies Working on Adult and Stem Cell Therapies
  • Table 3-3: Selected Cell Encapsulated Cell Therapeutics
  • Table 3-4: Selected Cell Therapy Products using Xenogenic Cells
  • Table 3-5: Selected Cell Therapy Equipment and Accessories
  • Table 3-6: Selected Cell and Tissue Bioengineered Products

Chapter Five: Cell Therapy Applications: Commercial and Non-Commercial Research

  • Table 5-1: Selected Cancer Vaccine Programs
  • Table 5-2: Selected Stem Cell Therapies for Cardiovascular Disease
  • Table 5-3: Selected Diabetes Cell Therapy Products
  • Table 5-4: Selected Neural Stem Cell Therapies
  • Table 5-5: Selected Organ Bioengineering Programs

Chapter Six: Market Analysis

  • Table 6-1: Number of Patients in Selected Cell Therapy Target Populations in the United States
  • Table 6-2: Worldwide Market for Selected Cell Therapies by Type 2002-2007
  • Table 6-3: Sales of the Leading Skin Replacement Products 2002
  • Table 6-4: Cell Replacement Procedures by Region 2002-2007
  • Figure 6-1: Technology Penetration Forecast for Cell Therapy Technologies

Chapter Eight: Companies and Technologies to Watch

  • Table 8-1: Strength Analysis of 22 Selected Cell Therapy Companies
  • Table 8-2: Kalorama’s Short List of Cell Therapy Companies

 

    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024
    September 11, 2024
    Worldwide Sequencer Market, 2023-2028
    August 8, 2024
    The Worldwide Market for Liquid Biopsy, 6th Edition
    December 29, 2023
    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023

Related products

  • Placeholder image

    Worldwide Market for Orthopedic Biomaterials, The

    $2,625.00 – $5,250.00
  • Placeholder image

    Immunomodulators in Cancer Therapy: Emerging Products and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    The Future of Biotechnology Instrumentation

    $2,995.00 – $5,990.00
  • Placeholder image

    Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments – World Market

    $995.00 – $3,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
U.S. Market for OTC Diet Aids, TheGrowth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline
Scroll to top